Biologic Therapy for Refractory Rheumatic Diseases Multidisciplinary Outpatient Clinic

Introduction

This outpatient clinic has been jointly established by experts from the Department of Rheumatology and Immunology, the Department of Hematology/Cell Therapy Center, and the Department of Hepatology and Infectious Diseases, focusing on breakthrough biologic therapies for refractory rheumatic diseases unresponsive to conventional treatment (such as systemic lupus erythematosus, inflammatory myopathies, systemic sclerosis, rheumatoid arthritis, etc.). Relying on cutting-edge technologies such as CAR-T cell therapy, novel biologics, and targeted immunotherapy, it provides patients with an integrated solution encompassing precise assessment-treatment-long-term management.